قالب وردپرس درنا توس
Home / Health / FDA expands recall of blood pressure medication for the fifth time this year

FDA expands recall of blood pressure medication for the fifth time this year



Recent emails

Receive breaking news and special reports. The news and stories that mattered provided the day of the week in the morning.

SUBSCRIBE

By Shamard Charles,

The Food and Drug Administration announced Wednesday it will extend the recall of blood pressure medicines to four losartan quantities after it has been found to contain a cancer-causing chemical.

This is the fifth call back in 201

9; In the past year, dozens of batches of drugs for the treatment of hypertension have been recalled because of fears of contamination.

According to the FDA, Legacy Pharmaceutical Packaging recalled four batches of losartan because the batch contained trace amounts of nitrosamine. which is associated with an increased risk of bladder cancer. In January, several generic valsartan products sold in the US were contaminated with NDMA, another nitrosamine chemical associated with an increased risk of colon and uterine cancer.


Source link